Design, synthesis, and struc-ture-activity relationships of pyrazolo[3,4-d]pyrimidinies:: a novel class of potent enterovirus inhibitors

被引:97
作者
Chern, JH [1 ]
Shia, KS
Hsu, TA
Tai, CL
Lee, CC
Lee, YC
Chang, CS
Tseng, SN
Shih, SR
机构
[1] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Taipei 114, Taiwan
[2] Chang Gung Univ, Sch Med Technol, Taoyuan 333, Taiwan
关键词
enterovirus inhibitor;
D O I
10.1016/j.bmcl.2004.02.092
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of pyrazolo[3,4-d]pyrimidines were synthesized. and their antiviral activity was evaluated in a plaque reduction assay. It is very interesting that this class of compounds provide remarkable evidence that they are very specific for human enteroviruses, in particular, coxsackieviruses. Some derivatives proved to be highly effective in inhibiting enterovirus replication at nanomolar concentrations. SAR studies revealed that the phenyl group at the N-I position and the hydrophobic diarylmethyl group at the piperazine largely influenced the in vitro antienteroviral activity of this new class of potent antiviral agents. It was found that the pyrazolo[3,4-d]pyrimidines with a thiophene substituent, such as compounds 20 24, in general exhibited high activity against coxsackievirus B3 (IC50 = 0.063-0.089 muM) and moderate activity against enterovirus 71 (IC50 = 0.32-0.65 muM) with no apparent cytotoxic effect toward RD (rhabdomyosarcoma) cell lines (CC50>25 muM). (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2519 / 2525
页数:7
相关论文
共 18 条
[1]  
AMUDA GM, 1987, PEDIATR INFECT DIS J, V6, P206
[2]  
CHONMAITREE T, 1981, PEDIATRICS, V67, P489
[3]   New purines and purine analogs as modulators of multidrug resistance [J].
Dhainaut, A ;
Regnier, G ;
Tizot, A ;
Pierre, A ;
Leonce, S ;
Guilbaud, N ;
KrausBerthier, L ;
Atassi, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (20) :4099-4108
[4]   OUTBREAK OF ENTEROVIRUS-71 INFECTION IN VICTORIA, AUSTRALIA, WITH A HIGH-INCIDENCE OF NEUROLOGIC INVOLVEMENT [J].
GILBERT, GL ;
DICKSON, KE ;
WATERS, MJ ;
KENNETT, ML ;
LAND, SA ;
SNEDDON, M .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1988, 7 (07) :484-488
[5]   The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-α]-pyrimidine:: A corticotropin-releasing factor (hCRF1) antagonist [J].
Gilligan, PJ ;
Baldauf, C ;
Cocuzza, A ;
Chidester, D ;
Zaczek, R ;
Fitzgerald, LW ;
McElroy, J ;
Smith, MA ;
Shen, HSL ;
Saye, JA ;
Christ, D ;
Trainor, G ;
Robertson, DW ;
Hartig, P .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (01) :181-189
[6]   OUTBREAK OF POLIOMYELITIS-LIKE PARALYSIS ASSOCIATED WITH ENTEROVIRUS-71 [J].
HAYWARD, JC ;
GILLESPIE, SM ;
KAPLAN, KM ;
PACKER, R ;
PALLANSCH, M ;
PLOTKIN, S ;
SCHONBERGER, LB .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1989, 8 (09) :611-616
[7]   4-(1,3-dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)-pyrazolo[1,5-a]-1,3,5-triazine:: A portent, orally bioavailable CRF1 receptor antagonist [J].
He, LQ ;
Gilligan, PJ ;
Zaczek, R ;
Fitzgerald, LW ;
McElroy, J ;
Shen, HSL ;
Saye, JA ;
Kalin, NH ;
Shelton, S ;
Christ, D ;
Trainor, G ;
Hartig, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (03) :449-456
[8]   An epidemic of enterovirus 71 infection in Taiwan [J].
Ho, MT ;
Chen, ER ;
Hsu, KH ;
Twu, SJ ;
Chen, KT ;
Tsai, SF ;
Wang, JR ;
Shih, SR .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (13) :929-935
[9]   OUTBREAKS OF HAND, FOOT, AND MOUTH-DISEASE BY ENTEROVIRUS 71 - HIGH-INCIDENCE OF COMPLICATION DISORDERS OF CENTRAL NERVOUS-SYSTEM [J].
ISHIMARU, Y ;
NAKANO, S ;
YAMAOKA, K ;
TAKAMI, S .
ARCHIVES OF DISEASE IN CHILDHOOD, 1980, 55 (08) :583-588
[10]   In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses [J].
Kaiser, L ;
Crump, CE ;
Hayden, FG .
ANTIVIRAL RESEARCH, 2000, 47 (03) :215-220